Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-1Ra in Type 2 Diabetes
NCT00303394Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Apr 2004
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing IL-1Ra with Placebo (2 arms). Primary endpoint: Glycosylated Hemoglobin at 52 weeks. Started Apr 2004; status: completed.
02
Drugs
anakinra
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00303394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303394.